000 01579 a2200445 4500
005 20250518071621.0
008 ####s 0 0 eng d
022 _a2234-943X
024 7 _a10.3389/fonc.2019.01178
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDíaz-Redondo, Tamara
245 0 0 _aDifferent Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data.
_h[electronic resource]
260 _bFrontiers in oncology
_c2019
300 _a1178 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aLavado-Valenzuela, Rocio
700 1 _aJimenez, Begoña
700 1 _aPascual, Tomas
700 1 _aGálvez, Fernando
700 1 _aFalcón, Alejandro
700 1 _aAlamo, Maria Del Carmen
700 1 _aMorales, Cristina
700 1 _aAmerigo, Marta
700 1 _aPascual, Javier
700 1 _aSanchez-Muñoz, Alfonso
700 1 _aGonzález-Guerrero, Macarena
700 1 _aVicioso, Luis
700 1 _aLaborda, Aurora
700 1 _aOrtega, Maria Victoria
700 1 _aPerez, Lidia
700 1 _aFernandez-Martinez, Aranzazu
700 1 _aChic, Nuria
700 1 _aJerez, Jose Manuel
700 1 _aAlvarez, Martina
700 1 _aPrat, Aleix
700 1 _aRibelles, Nuria
700 1 _aAlba, Emilio
773 0 _tFrontiers in oncology
_gvol. 9
_gp. 1178
856 4 0 _uhttps://doi.org/10.3389/fonc.2019.01178
_zAvailable from publisher's website
999 _c30335454
_d30335454